UCL (University College London)
This programme builds on the recent successes in clinical applications of immunotherapy for a range of immune-mediated diseases and, drawing on faculty-wide expertise, focuses on the processes involved in translating immunobiology research, using the eye as a model.
A medical degree or a minimum of an upper 2nd Class UK Honours degree in biomedical science, or another relevant discipline, or an overseas qualification of an equivalent standard. If your education has not been conducted in the English language, you will be expected to demonstrate evidence of a good level of English proficiency.
Developing translational research; masterclasses in translational immunobiology; ocular immunology; research in practice; translating science into the clinic; cost benefit analysis and health; genetics and epidemiology of ocular disease; modern aspects of drug discovery; ocular cell biology; ocular development in health and disease; pharmacogenomics, adverse drug reactions and biomarkers.
The programme is delivered through a combination of lectures, seminars and student group presentations. Assessment is through a mixture of unseen examinations, coursework (essays, bioinformatic tasks, practicals), a major dissertation, and oral presentations.
|Qualification||Study mode||Fee||Course duration|
|MSc||Full-time||£ 10,130 per Academic year (home fees)||1 years|
|MSc||Full-time||£ 24,400 per Academic year (overseas fees)||1 years|
|Campus name||Town||Postcode||Region||Main campus||Campus||Partner|
020 7608 6800